Efficacy and Safety of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations
Clinical trial NCT07054632 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07054632
- Sponsor
- Innostellar Biotherapeutics Co.,Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-13
- Primary completion
- 2025-08-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.